1. |
Cunningham SC, Kamangar F, Kim MP, et al. Claudin4, mitogenactivated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions [J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(2): 281287.
|
2. |
Konturek PC, Kania J, Konturek JW, et al. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX2, PPAR γ and impaired apoptosis in gastric carcinogenesis [J]. Med Sci Monit, 2003, 9(7): SR53SR66.
|
3. |
Hu C, Yi C, Hao Z, et al. The effect of somatostatin and SSTR3 on proliferation and apoptosis of gastric cancer cells [J]. Cancer Biol Ther, 2004, 3(8): 726730.
|
4. |
Matsubara J, Yamada Y, Nakajima TE, et al. Clinical significance of insulinlike growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer [J]. Oncology, 2008, 74(12): 7683.
|
5. |
Ito M, Tanaka S, Maeda M, et al. Role of the gastringastrin receptor system in the expansive growth of human gastric neoplasms [J]. Digestion, 2008, 78(23): 163170.
|
6. |
叶序卷, 王立. 胃癌与相关胃肠激素的关系研究进展 [J]. 国际消化病杂志, 2006, 26(4): 253256.
|
7. |
Maev IV, Mel’nikova EV, Kashin SV, et al. Serologic screening for preneoplastic pathology and early stomach cancer [J]. Klin Med (Mosk), 2008, 86(11): 4348.
|
8. |
Kamerling IM, Van Haarst AD, Burggraaf J, et al. Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers [J]. Am J Physiol Gastrointest Liver Physiol, 2003, 284(5): G776G781.
|
9. |
Sanger GJ. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases [J]. Drug Discov Today, 2008, 13(56): 234239.
|
10. |
Pendleton H, Ekman R, Olsson R, et al. Motilin concentrations in relation to gastro intestinal dysmotility in diabetes mellitus [J]. Eur J Intern Med, 2009, 20(6): 654659.
|
11. |
National Comprehensive Cancer Network. NCCN胃癌临床实践指南(中国版)专家组. 胃癌临床实践指南(中国版) [S]. 2009: 20.
|
12. |
Itoh Z. Motilin and clinical application [J]. Peptides, 1997, 18(4): 593608.
|
13. |
Xu L, Depoortere I, Tang M, et al. Identification and expression of the motilin precursor in the guinea pig [J]. FEBS Lett, 2001, 490(12): 710.
|
14. |
Xu L, Depoortere I, Tomasetto C, et al. Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus [J]. Regul Pept, 2005, 124(13): 119125.
|
15. |
Takeshita E, Matsuura B, Dong M, et al. Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract [J]. J Gastroenterol, 2006, 41(3): 223230.
|
16. |
Ter Beek WP, Muller ES, van den Berg M, et al. Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine [J]. Inflamm Bowel Dis, 2008, 14(5): 612619.
|
17. |
Ozaki K, Yogo K, Sudo H, et al. Effects of mitemcinal (GM611), an acidresistant nonpeptide motilin receptor agonist on the gastrointestinal contractile activity in conscious dogs [J]. Pharmacology, 2007, 79(4): 223235.
|
18. |
McCallum RW, Cynshi O. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesisa randomized, multicentre, placebocontrolled study [J]. Aliment Pharmacol Ther, 2007, 26(8): 11211130.
|
19. |
De Smet B, Mitselos A, Depoortere I. Motilin and ghrelin as prokinetic drug targets [J]. Pharmacol Ther, 2009, 123(2): 207223.
|
20. |
Trudel L, Tomasetto C, Rio MC, et al. Ghrelin/motilinrelated peptide is a potent prokinetic to reverse gastric postoperative ileus in rat [J]. Am J Physiol Gastrointest Liver Physiol, 2002, 282(6): G948G952.
|
21. |
邓钢明, 袁庆丰. 胃癌患者血浆胃动素与胃收缩运动的关系探讨 [J]. 蚌埠医学院学报, 2001, 26(3): 245.
|
22. |
龙宪和. 胃肠肝等癌症患者血浆胃动素观察的临床意义 [J]. 标记免疫分析与临床, 2003, 10(3): 181182.
|
23. |
吕宾, 叶再元, 朱林喜, 等.胃癌组织及癌区动、静脉血胃肠激素的研究 [J]. 世界华人消化杂志, 2000, 8(12): 14291430.
|
24. |
杨小慧, 刘勇刚, 陈海鹰, 等. 消化道肿瘤患者化疗前后血浆胃动素和降钙素基因相关肽的变化 [J]. 中国基层医药, 2008, 15(1): 2021.
|
25. |
刘建平. 化浊解毒汤对慢性萎缩性胃炎大鼠MTL、SS、ET的影响 [D]. 河北: 河北医科大学, 2009: 2639.
|